Skip to main content
. 2016 Mar 24;11(3):e0152326. doi: 10.1371/journal.pone.0152326

Fig 2. mAbs R54 and B2 both specifically recognize CD43.

Fig 2

(A) FACS plots showing the course of the enrichment of R54-positive cells from YB2/0 cells transduced with a MLL/AF9 leukemia cell–derived cDNA library. (B) FACS analysis of the binding of S11, R54, or B2 mAb to splenocytes from wild-type or CD43-deficient mice.